Bayer Posts Strong Phase III Results for Asundexia...
Category : Clinical Trial Update 26 November 2025Bayer has shared encouraging topline results from its OCEANIC-STROKE Phase III trial, testing asunde...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Viking Therapeutics to Join Piper Sandler’s 37th A...
Category : Clinical Trial Update 26 November 2025Viking Therapeutics is stepping into the spotlight this December. The metabolic-drug developer will...
Cornell Launches New Study on Once-Weekly GLP-1 Th...
Category : Clinical Trial Update 26 November 2025Feline obesity is rising fast, and veterinarians have few effective tools to manage it. Now, a Corne...
New $1.9M DoD-Funded Trial Aims to Improve Swallow...
Category : Clinical Trial Update 25 November 2025Swallowing problems, or dysphagia, affect up to 80% of people with Parkinson’s disease. These...
Innocan Pharma Publishes Promising New Research on...
Category : Product Related Updates 25 November 2025Chronic pain management is stuck in an old loop—opioids, short-acting therapies, and inconsist...
Latest Newsletter Post
-
Cornell Launches New Study on Once-..
26 November 2025
-
Viking Therapeutics to Join Piper S..
26 November 2025
-
Bayer Posts Strong Phase III Result..
26 November 2025
-
GEMMABio’s Next-Gen SMA1 Gene Thera..
25 November 2025
-
Novo Nordisk’s Alzheimer’s Trials M..
25 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com